Receptor Mechanisms and Signaling
Moving in bioRxiv, Nature, Nature Communications, Biotechnology advances, Cell Reports, Communications Biology, eLife and medRxiv.
- Moved, week to 22 Oct 2026
- 0
- Papers in 60 days
- 40
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Receptor Mechanisms and Signaling
Newest first · last 60 days
A human-specific antibody selectively inhibits interleukin-6 trans-signalling while preserving classic signalling, revealing distinct receptor assembly mechanisms.
- Open access
Allosteric disulfide bond switching in KIR2DL4 regulates HLA-G binding and endocytosis, with the Cys10-Cys28 bond controlling receptor activation in human NK cells.
- Open access
Blocking cholinergic interneurons in the nucleus accumbens prevents morphine-conditioned place preference without affecting dopamine increases in mice.
Bispecific antibody chimeras (GTACs) induce receptor degradation, achieving over 100-fold greater potency than traditional antagonists for multiple GPCRs.
- Open access
11.3% of randomly modified ligands across six targets improved potency tenfold or more, revealing a surprising baseline for ligand optimization success.
- Open access
Browse JClub
Journals this month
- bioRxiv6054
- medRxiv1746
- PNAS447
- Sci Adv354
- JAMA268
- Environ Res246
- BMJ196
- Nat Commun173
- Environ Pollution167
- Nature151
- Science141
- Lancet128
- Cell Rep127
- NEJM118
- Plant Cell Environ114
- Applied & Environ Microbio112
- Curr Biol106
- Blood105
Topics moving, week to 22 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Cancer Immunotherapy and Biomarkers5
- Gut microbiota and health5
- Cancer Genomics and Diagnostics4
- Bacteriophages and microbial interactions4
- CAR-T cell therapy research3
- Lung Cancer Treatments and Mutations3
- Liver Disease Diagnosis and Treatment3
- Dementia and Cognitive Impairment Research3
